Table 2.
Selected outcome measures |
Baseline (mean ± SE) | TT Baseline correlated * to Baseline outcome values |
Change Baseline to Week 8 (mean ± SE) |
TT change correlated * to change from Baseline to Week 8 |
---|---|---|---|---|
Tampon test | 4.67 ± 0.19 | 1.00 | −1.53 ± 0.19 | 1.00 |
Overall pain (24 hrs.) | 1.90 ± 0.16 | 0.38 (0.23, 0.52); P < 0.0001 | −0.60 ± 1.19 | 0.42 (0.24, 0.55); P < 0.0001 |
Intercourse pain | 5.82 ± 0.24 | 0.22 (0.05, 0.38); P = 0.04 | −1.60 ± 0.23 | 0.35 (0.17, 0.50); P = 0.003 |
CST (vestibule) | 22.12 ± 0.46 | 0.11 (−0.06, 0.28); P = 0.21 | −9.13 ± 0.94 | 0.38 (0.21, 0.53); P < 0.0001 |
CST (vagina) | 2.39 ± 0.27 | 0.08 (−0.10, 0.25); P = 0.40 | −0.76 ± 0.33 | 0.12 (−0.07, 0.30); P = 0.23 |
Algesiometer | 10.70 ± 0.63 | −0.16 (−0.33, 0.00); P = 0.06 | 5.68 ± 1.14 | −0.33 (−0.49,−0.15); P = 0.0004 |
Pelvic muscle pain (mean) | 0.64 ± 0.05 | −0.09 (−0.25, 0.08); P = 0.34 | −0.17 ± 0.05 | 0.12 (−0.06, 0.30); P = 0.19 |
SF-MPQ total score | 13.56 ± 0.76 | 0.15 (−0.03, 0.31); P = 0.11 | −4.92 ± 0.74 | 0.23 (0.04, 0.40); P = 0.02 |
SF-MPQ affective subscale | 2.50 ± 0.27 | 0.13 (−0.04, 0.30); P = 0.16 | −1.27 ± 0.26 | 0.16 (−0.03, 0.33); P = 0.12 |
SF-MPQ sensory subscale | 10.96 ± 0.60 | 0.19 (0.02, 0.35), P = 0.054 | −3.73 ± 0.58 | 0.30 (0.12, 0.46); P = 0.0052 |
Brief Pain Inventory | 20.46 ± 1.60 | 0.34 (0.17, 0.48); P < 0.0001 | −7.91 ± 1.60 | 0.49 (0.34, 0.62); P < 0.0001 |
Neuropathic Pain Scale | 43.69 ± 1.37 | 0.19 (0.01, 0.35); P = 0.03 | −12.7 ± 1.52 | 0.33 (0.16, 0.49); P = 0.0005 |
Beck Depression Inventory | 9.58 ± 0.79 | 0.03 (−0.14, 0.21); P = 0.71 | ** | ** |
Profile of Mood States | 86.68 ± 2.75 | 0.10 (−0.07, 0.27); P = 0.29 | ** | ** |
SF-MPQ = Short-form McGill Pain Questionnaire
Pearson Correlation Coefficient (95% C.I.)
not available at Week—8
CST = Cotton Swab Test
TT = Tampon Test